TAO Synergies Inc.

TAOX

NASDAQTechnologySoftware - Application

Open in GoAI

Latest quote

$3.96

+$0.15 · +3.94%

Company profile

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

TAO Synergies Inc.

TAOX

NASDAQTechnologySoftware - Application

Open in GoAI

Regular session

$3.96

+$0.15 · +3.94%

Oct 9, 11:44 AM ET

Latest quote

$3.96

+$0.15 · +3.94%

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

34/ 100

GoAI Score

Sell

Valuation

Fair Value

Sentiment

Mixed

Risk

High Risk

Momentum

Strong Down

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Industry: Software - Application
Sector: Technology
Headquarters: US
CEO: Joshua N. Silverman
Listed since: Jul 2, 2025
Employees: 5

Market position

Day range

Current $3.96

$3.73$3.97

52-week range

Current $3.96

$3.065$10.00

Open: $3.88
Previous close: $3.81
Volume: 55.58K; 0.37× average
Average volume: 148.49K; Average daily volume
Market cap: 29.59M USD
Beta: 1.5; Market reference 1
50-day average: $3.9187; +1.05% above average
200-day average: $4.3962; -9.92% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 6.65M USD
P/E (TTM): -0.99×
P/B (TTM): 1.71×
P/S (TTM): 38.3×
EV / EBITDA: -0.74×
Earnings yield: -236.62%
Free cash flow yield: -52.66%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 99.90%
Operating margin: -1085.25%
Net margin: -2155.49%
Return on equity: -131.23%
Return on assets: -111.23%
Return on invested capital: -37.66%

Financial health

Debt / equity: 0×
Current ratio: 13.99×
Altman Z-score: -1.29
Piotroski F-score: 2 of 9

Financial statements

Income trends

Operating income

−9.05M USD-32.84%

Net income

−28.74M USD-125.06%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	299.06K USD	—	—	—	—
Gross profit	299.06K USD	—	—	—	—
Research and development	322.23K USD	1.6M USD	1.97M USD	6.32M USD	4.34M USD
Selling, general, and administrative	9.02M USD	5.21M USD	6.34M USD	9.81M USD	8.28M USD
Operating expenses	9.35M USD	6.81M USD	8.31M USD	16.13M USD	12.62M USD
Interest income	442.91K USD	1.28M USD	1.65M USD	335.04K USD	7.11K USD
Depreciation and amortization	3.62K USD	5.58K USD	6.35K USD	5.71K USD	4.97K USD
Operating income	−9.05M USD	−6.81M USD	−8.31M USD	−16.13M USD	−12.62M USD
Net income	−28.74M USD	−12.77M USD	−6.04M USD	−5.57M USD	−12.61M USD

Company facts updated Oct 9, 2026.

Earnings

EPS beat rate: 67%; 4 beats, 2 misses, 0 met estimates
Average EPS surprise: +11.94%; 6 comparable reports
Latest EPS result: -1.83; Estimate -12.75 · Beat by 85.65%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

TAOX news

defenseworld.netSep 8, 2026

Synaptogenix (NASDAQ:TAOX) & Shineco (NASDAQ:SISI) Head-To-Head Contrast

Synaptogenix (NASDAQ: TAOX - Get Free Report) and Shineco (NASDAQ: SISI - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of…

Read source

benzinga.comAug 5, 2026

James Altucher Prefers AI's Picks And Shovels; Calls Quantum Computing Science Fiction

Credit: James Altucher(an investor, venture capitalist, writer, entrepreneur, co-Founder TAO Synergies) and Anna Tutova(Founder AI Crypto Minds) at Proof of Talk Summit in Paris.

Read source